Core Scientific Reports Warrant Exercises

TL;DR

Core Scientific saw warrant exercises on Dec 5th, potentially bringing in cash.

AI Summary

Core Scientific, Inc. filed an 8-K on December 5, 2024, reporting on warrant exercises. Specifically, the company noted exercises for warrants with an exercise price of $6.81 per share and $0.01 per share, both occurring on December 5, 2024. This filing also includes financial statements and exhibits.

Why It Matters

This filing indicates potential new capital infusion into Core Scientific through the exercise of outstanding warrants, which could impact the company's financial structure.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of warrant exercises and does not indicate any significant new risks.

Key Numbers

• $6.81 — Warrant Exercise Price (One of the exercise prices reported for warrants on December 5, 2024.)
• $0.01 — Warrant Exercise Price (Another exercise price reported for warrants on December 5, 2024.)

Key Players & Entities

• Core Scientific, Inc. (company) — Registrant
• December 5, 2024 (date) — Date of Report and Warrant Exercise
• $6.81 (dollar_amount) — Warrant Exercise Price
• $0.01 (dollar_amount) — Warrant Exercise Price
• Power & Digital Infrastructure Acquisition Corp. (company) — Former Company Name

FAQ

Key Financial Figures

• $0.00001 — ich registered Common stock, par value $0.00001 per share CORZ The Nasdaq Global Selec
• $6.81 — of common stock at an exercise price of $6.81 per share CORZW The Nasdaq Global Sel
• $0.01 — of common stock at an exercise price of $0.01 per share CORZZ The Nasdaq Global Sel

Filing Documents

• core-20241205.htm (8-K) — 35KB
• corznovemberupdaterelease.htm (EX-99.1) — 35KB
• image1a.jpg (GRAPHIC) — 2KB
• image2a.jpg (GRAPHIC) — 3KB
• image_2a.jpg (GRAPHIC) — 42KB
• imagea.jpg (GRAPHIC) — 7KB
• 0001628280-24-050075.txt ( ) — 329KB
• core-20241205.xsd (EX-101.SCH) — 3KB
• core-20241205_def.xml (EX-101.DEF) — 17KB
• core-20241205_lab.xml (EX-101.LAB) — 30KB
• core-20241205_pre.xml (EX-101.PRE) — 17KB
• core-20241205_htm.xml (XML) — 5KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure On December 5, 2024, the Company issued a press release announcing certain production and operations updates for the month of November 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 7.01 by reference. The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language except as expressly set forth by specific reference in such filing.

01 Financial Statement and Exhibits

Item 9.01 Financial Statement and Exhibits (d) Exhibits: Exhibit No. Description 99.1 Press Release dated December 5, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Core Scientific, Inc. Dated: December 5, 2024 By: /s/ Todd M. DuChene Name: Todd M. DuChene Title: Chief Legal Officer and Chief Administrative Officer

View Full Filing

View this 8-K filing on SEC EDGAR